pVACseqΒΆ
pVACseq is a cancer immunotherapy pipeline for the identification of personalized Variant Antigens by Cancer Sequencing (pVACseq) that integrates tumor mutation and expression data (DNA- and RNA-Seq). It enables cancer immunotherapy research by using massively parallel sequence data to predict tumor-specific mutant peptides (neoantigens) that can elicit anti-tumor T cell immunity. It is being used in studies of checkpoint therapy response and to identify targets for personalized cancer vaccines and adoptive T cell therapies. For more general information, see the manuscript published in Cancer Immunology Research.
- Features
- Input File Preparation
- Getting Started
- Usage
- Output Files
- Filtering Commands
- Additional Commands
- Optional Downstream Analysis Tools
- Generate Protein Fasta
- Generate Aggregated Report
- Add Evaluation Predictions Using a Pre-Trained Machine Learning Model
- Calculate Reference Proteome Similarity
- NetChop Predict Cleavage Sites
- NetMHCStab Predict Stability
- Identify Problematic Amino Acids
- Mark Genes of Interest
- Update Tiers
- Create Peptide Ordering Form
- Common Errors
- Frequently Asked Questions